Clinical Trial Update: One Touch® Verio®IQ European Clinical Outcomes Study [Phase 4]

View source ↗

Summary

The OneTouch VerioIQ European Clinical Outcomes Study (Phase 4) sponsored by LifeScan has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• OneTouch VerioIQ

Snippet

Sponsor: LifeScan | Conditions: Diabetes | Phase 4 | Status: WITHDRAWN